Evidence map›Paper›PMID 42086641›Full record

ArticleScientific reports2026

Antimicrobial and anticancerogenic activity of selenium nanoparticles obtained via pulsed laser ablation.

Entidhar Jasim Khamees, Lubna Abdulazeem, Zaytoon Abdulrida Al-Khafaji, Olcay Gençyılmaz

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Entidhar Jasim KhameesDepartment of Physiology and Medical Physics, Babylon University, Hilla, Iraq. med.intidhar.jasim@uobabylon.edu.iq.
Lubna AbdulazeemDNA-Research Center, University of Babylon, Hilla, Iraq.
Zaytoon Abdulrida Al-KhafajiDepartment of Microbiology, College of Medicine, University of Babylon, Hilla, Iraq.
Olcay GençyılmazDepartment of Physics, Çankırı Karatekin University, Çankırı, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SeNPs were synthesized via chemical reduction and physical pulsed laser ablation techniques. Stable, spherical nanoparticles with TEM diameters ranging from 20 to 150 nm (mean ± SD: 28.5 ± 7.2 nm and 33.8 ± 6.4 nm for the chemical and physical methods, respectively) were obtained. The characteristic absorption peaks at 310 nm and 371 nm were detected for SeNPs produced by chemical reduction and physical pulsed laser ablation, respectively. The band gap values were found to be 1.74 eV and 1.92 eV, respectively. Zeta potential analysis confirmed moderate colloidal stability (23.67 mV and 25.17 mV for chemical and physical reduction, respectively). The antibacterial activities of the SeNPs against E. coli, Klebsiella spp., Pseudomonas spp. and Staphylococcus spp. were evaluated using the agar well diffusion method. SeNPs synthesized by the chemical reduction method formed inhibition zones of 10, 14, 18, 20 and 27 mm (E. coli); 9-18 mm (Staphylococcus spp.); 10-17 mm (Klebsiella spp.); and 8-16 mm (Pseudomonas spp.). Particles synthesized by physical pulsed laser ablation formed equivalent zones of 9-24 mm, 8-16 mm, 9-17 mm, and 7-15 mm. A particularly notable result was the strain- and dose-dependent difference identified by one-way ANOVA (F = 3304.3, p < 1 × 10⁻

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsMetal NanoparticlesNanoparticlesSeleniumCaco-2 CellsCell SurvivalEscherichia coliHumansLaser TherapyMicrobial Sensitivity TestsParticle SizeAnti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsSeleniumAntibacterial-anticancer CaCo-2 MTT assayChemical reductionLaser ablationSelenium nanoparticles

Identifiers

PMID42086641
PMCPMC13334010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.